Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans

[1]  K. Schenck-Gustafsson,et al.  Time-dependent variation in the cardiac conduction system assessed in young healthy individuals at weeks' interval: implications for clinical trials. , 1991, Journal of the American College of Cardiology.

[2]  C. Dubray,et al.  Comparative Effects of Disopyramide and Its Mono- N-Dealkylated Metabolite in Conscious Dogs with Chronic Atrioventricular Block: Plasma Concentration‐Response Relationships , 1986, Journal of cardiovascular pharmacology.

[3]  K. Schenck-Gustafsson,et al.  Kinetics and dynamics of disopyramide and its dealkylated metabolite in healthy subjects , 1985, Clinical pharmacology and therapeutics.

[4]  O. Nyquist,et al.  Determination of (R)- and (S)-Disophyramide in human plasma using a chiral α1-acid glycoprotein column , 1984 .

[5]  A. Camm,et al.  Class 1 antiarrhythmic drugs--characteristic electrocardiographic differences when assessed by atrial and ventricular pacing. , 1984, European heart journal.

[6]  G. Solders,et al.  R‐R variations in Guillain‐Barré syndrome: a test of autonomic dysfunction , 1983, Acta neurologica Scandinavica.

[7]  A. Camm,et al.  The Direct Electrophysiologic Effects of Disopyramide Phosphate in the Transplanted Human Heart , 1983, Circulation.

[8]  P. K. Lunde,et al.  Plasma binding of disopyramide and mono-N-dealkyldisopyramide. , 1982, British journal of clinical pharmacology.

[9]  A. Masoni,et al.  Electrophysiology of Normal Sinus Node With and Without Autonomic Blockade , 1982, Circulation.

[10]  T. Colatsky.  Mechanisms of Action of Lidocaine and Quinidine on Action Potential Duration in Rabbit Cardiac Purkinje Fibers: An Effect on Steady State Sodium Currents? , 1982, Circulation research.

[11]  S. Ankier,et al.  Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle. , 1978, European journal of pharmacology.

[12]  R. Ensslen,et al.  Vagal tone, significance of electrophysiologic findings and clinical course in symptomatic sinus node dysfunction. , 1978, American heart journal.

[13]  P. Lagerström,et al.  Liquid chromatography in the monitoring of plasma levels of antiarrhythmic drugs. , 1978, Journal of chromatography.

[14]  E. V. Vaughan Williams,et al.  Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. , 1977, British heart journal.

[15]  E. R. Garrett,et al.  Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans , 1976, Journal of Pharmacokinetics and Biopharmaceutics.

[16]  G. Ferrier,et al.  Relationship of the Functional Refractory Period to Conduction in the Atrioventricular Node , 1974 .

[17]  R. Gilmour,et al.  New concepts of antiarrhythmic drug actions. , 1986, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[18]  O. Nyquist,et al.  Determination of (R)- and (S)-disopyramide in human plasma using a chiral alpha 1-acid glycoprotein column. , 1984, Journal of chromatography.

[19]  D. Roden,et al.  Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramide. , 1983, Pharmacology & therapeutics.

[20]  J. Davies,et al.  Some pharmacological effects of disopyramide and a metabolite. , 1976, The Journal of international medical research.

[21]  Davies Je,et al.  Some pharmacological effects of disopyramide and a metabolite. , 1976 .